CRACR2A and metabolic dysfunction-associated steatotic liver disease: Here we utilized an Efcab4b global knockout mouse to explore the impact of CRACR2A and Rab46 depletion on liver and to identify some potential pathways that contribute to inflammation/progression of NAFLD.